AstraZeneca and Oracle Join Forces to Make Clinical Trials Smarter With AI
AstraZeneca has partnered with Oracle to explore the use of artificial intelligence (AI) and real-world health data to improve clinical trial recruitment, strengthen safety monitoring...
Domestic Manufacturing Breakthroughs Drive Drastic Price Reductions for Rare Disease Therapies in India
Under the National Policy for Rare Diseases (NPRD), the Government of India provides one-time financial assistance of up to ₹50 lakh per patient across...
Minor Fire Reported at Aurobindo Pharma’s Unit-15 in Andhra Pradesh; No Casualties
A minor fire incident was reported at Aurobindo Pharma Limited’s Unit 15, located within Jawaharlal Nehru Pharma City in Parawada, Anakapalli district, Andhra Pradesh. The company confirmed that all...
Department of Pharmaceuticals Constitutes High-Level Committee to Overhaul Regulatory Oversight of Pharmaceutical Marketing Practices
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, has issued an official order constituting a high-level committee to conduct a comprehensive examination...
AstraZeneca’s Ultomiris Wins FDA’s approval to reduce proteinuria in adults
AstraZeneca’s rare-disease business, Alexion, has secured US Food and Drug Administration (FDA) accelerated approval for Ultomiris (ravulizumab) to reduce proteinuria in adults with primary immunoglobulin A...
Viatris to Acquire Pacira BioSciences for $1.65 Billion, Strengthening Non-Opioid Pain Portfolio
Viatris has agreed to acquire Pacira BioSciences for approximately $1.65 billion in an all-cash transaction, marking a significant step in its strategy to expand its...